Competing values in healthcare: balancing the (un)balanced scorecard.

Competing values in healthcare: balancing the (un)balanced scorecard. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Competing values in healthcare: balancing the (un)balanced scorecard. Abstract Text:

Angela M Wicks,Lynda St Clair,

Facing a complex environment driven by two decades of dramatic change, healthcare organizations are adopting new strategic frameworks such as the Balanced Scorecard (BSC) to evaluate performance (Kaplan and Norton 1992). The BSC was not originally developed as a performance management tool, however. Rather, it was designed as a tool to communicate strategy and, as such, provides little guidance when actual outcomes fall short of desired outcomes. In addition, although the BSC is an improvement over exclusively financial measures, it has three conceptual limitations that are especially problematic for evaluating healthcare organizations: (1) it underemphasizes the employee perspective, (2) it is founded on a control-based management philosophy, and (3) it emphasizes making trade-offs. To address these limitations, we propose using the Competing Values Framework (CVF), a theoretically grounded, comprehensive approach to understanding and improving organizational and managerial performance by focusing on four action imperatives: competing, controlling, collaborating, and creating. The CVF pays particular attention to the employee perspective, is consistent with a commitment-based management philosophy, and emphasizes transcending apparent paradoxes to identify win-win solutions. Rather than focusing on customer satisfaction or employee satisfaction, the CVF looks for ways to satisfy customers and employees while still addressing financial constraints and growth opportunities. The CVF also can be used to assess both the culture of the organization and the competencies of individual managers, thereby providing a clear link between strategy and implementation.

Competing values in healthcare: balancing the (un)balanced scorecard. Publishing Authors By Initials

AM Wicks,L St Clair,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Competing values in healthcare: balancing the (un)balanced scorecard. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of healthcare management / American Colleg

VOLUME: 52

Page Numbers: 309-23; discussion 323-4

Journal Abbreviation:

ISSN: 1096-9012

DAY: 20

MONTH: 11

YEAR: 2007

Competing values in healthcare: balancing the (un)balanced scorecard. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9803529

Competing values in healthcare: balancing the (un)balanced scorecard. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Competing values in healthcare: balancing the (un)balanced scorecard. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Competing values in healthcare: balancing the (un)balanced scorecard.

AFFILIATION: Management Department, Bryant University, Smithfield, Rhode Island, USA. awicks@bryant.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Healthc Manag

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Competing values in healthcare: balancing the unbalanced scorecard Related Publications

• A major QTL introgressed from wild Lycopersicon hirsutum confers chilling tolerance to cultivated tomato (Lycopersicon esculentum).
• A neuronal model of Alzheimer's disease: An insight into the mechanisms of oxidative stress-mediated mitochondrial injury.
• Adjuvant radiation of bilateral postauricular keloids: an illustration of technique.
• An unusual photoactivated skin eruption. Quinidine-induced livedo reticularis.
• B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
• Chronic exposure to 12-O-tetradecanoylphorbol-13-acetate represses sod2 induction in vivo: the negative role of p50.
• Collateral damage in cancer chemotherapy: oxidative stress in nontargeted tissues.
• Competing values in healthcare: balancing the (un)balanced scorecard.
• Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo.
• Erratum.
• Functional genomics and ecology - a tale of two scales.
• Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al2O3) nanoparticles in mouse skin epithelial cells.
• NF-kappaB-associated MnSOD induction protects against beta-amyloid-induced neuronal apoptosis.
• Natural variation among Arabidopsis thaliana accessions for transcriptome response to exogenous salicylic acid.
• Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury.
• RHIOs in reverse.
• ROS and p53: A versatile partnership.
• Redox proteomic identification of oxidized cardiac proteins in adriamycin-treated mice.
• SN52, a novel nuclear factor-{kappa}B inhibitor, blocks nuclear import of RelB:p52 dimer and sensitizes prostate cancer cells to ionizing radiation.
• School-based drug prevention among at-risk adolescents: effects of ALERT plus.
• Serum, urinary, and salivary nitric oxide in rheumatoid arthritis: complexities of interpreting nitric oxide measures.
• Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1alpha,25-dihydroxyvitamin D(3) in prostate cancer cells.
• The calm after the cytokine storm: lessons from the TGN1412 trial.
• The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN.
• The role of a single-stranded nucleotide loop in transcriptional regulation of the human sod2 gene.
• Tumor necrosis factor alpha-mediated nitric oxide production enhances manganese superoxide dismutase nitration and mitochondrial dysfunction in primary neurons: an insight into the role of glial cells.
• Unilateral, linear, zosteriform epidermal nevus with acantholytic dyskeratosis.